Anthony Coates is the Professor of Medical Microbiology at St George’s, University of London. His main research interests are in antibiotic development and in tuberculosis. For 30 years he worked with Professor Dennis Mitchison, the world expert in combination chemotherapy of tuberculosis. With Dr Yanmin Hu, Dr Coates invented a new platform technology to create novel patented combinations of repurposed or new antimicrobials which can rescue existing antibiotics. He founded the Antibiotic Biotech, Helperby Therapeutics plc, to develop new combinations, one of which is in the market, one has completed Phase II, two are in Phase II, and two are in late stage preclinical development. These combinations are potential new treatments for highly resistant bacterial infections including complicated urinary tract infections, Cystic Fibrosis, complicated skin infections, and disinfection.
He has been awarded numerous national and international grants from the European Commission, British MRC, charities and industry, and named inventor on over 128 patents with co-inventor Dr Yanmin Hu. He has published more than 180 peer-reviewed publications and 13 books as editor (ORCID: https://orcid.org/0000-0001-8052-3175),
He serves on the Scientific Advisory committee of the Global Antibiotic Research and Development Partnership(GARDP) and serves as a director on the board of Biotechs from Europe innovating in Anti-Microbial resistance Alliance (BEAM).
He founded the networks Antibiotic Discovery-UK, Antibiotic Discovery-Global, and co-founded BEAM and the world’s first antibiotic discovery charity called Antibiotic Research-UK.